Peptide-dependent vectors have gained focus for their specificity in binding to receptors overexpressed in breast most cancers cells, potentially overcoming difficulties connected to low internalization. Co-formulation with other permeation enhancers, enzyme inhibitors, and hydrogels have also been used to allow the oral administration of other